Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
05/18/2010
Trade Name:
Zymaxid
Generic Name or Proper Name (*):
gatifloxacin
Indications Studied:
Bacterial conjunctivitis
Label Changes Summary:
* Safety and effectiveness have been demonstrated in clinical trials for the treatment of bacterial conjunctivitis in pediatric patients 1 year and older * The safety and effectiveness in infants < 1year have not been established * Information on adverse reactions and clinical trials * New drug
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Allergan
NNPS:
FALSE
Therapeutic Category:
Antibiotic
-
-